Table of Content

1 Study Coverage
1.1 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product Introduction
1.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Outlook 2018 VS 2024 VS 2034
1.2.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size for the Year 2018-2034
1.2.2 United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size for the Year 2018-2034
1.3 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Dynamics
1.4.1 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Industry Trends
1.4.2 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Drivers
1.4.3 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Challenges
1.4.4 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody by Type
2.1 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Segment by Type
2.1.1 Monoclonal Antibody
2.1.2 Polyclonal Antibody
2.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018, 2024 & 2034)
2.3 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018-2034)
2.4 United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018, 2024 & 2034)
2.5 United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018-2034)
3 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody by Application
3.1 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Segment by Application
3.1.1 Flow Cytometry
3.1.2 ELISA
3.1.3 Western Blot
3.1.4 Immunoprecipitation
3.1.5 Immunofluorescence
3.1.6 Other
3.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018, 2024 & 2034)
3.3 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018-2034)
3.4 United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018, 2024 & 2034)
3.5 United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018-2034)
4 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Competitor Landscape by Company
4.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Company
4.1.1 Global Key Companies of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Ranked by Revenue (2024)
4.1.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue by Player (2018-2023)
4.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Concentration Ratio (CR)
4.2.1 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody in 2024
4.2.3 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Head office and Area Served
4.4 Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Product and Application
4.5 Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Company
4.7.1 Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody in United States, Ranked by Revenue (2024)
4.7.2 United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue by Players (2021, 2024 & 2023)
5 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region
5.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2018-2034)
5.2.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region: 2018-2023
5.2.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2024-2034)
6 Americas
6.1 Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth 2018-2034
6.2 Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type
6.2.1 Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018-2023)
6.2.2 Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2024-2034)
6.2.3 Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type (2018-2034)
6.3 Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application
6.3.1 Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018-2023)
6.3.2 Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2024-2034)
6.3.3 Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application (2018-2034)
6.4 Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth 2018-2034
7.2 EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type
7.2.1 EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018-2023)
7.2.2 EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2024-2034)
7.2.3 EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type (2018-2034)
7.3 EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application
7.3.1 EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018-2023)
7.3.2 EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2024-2034)
7.3.3 EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application (2018-2034)
7.4 EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth 2018-2034
8.2 China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type
8.2.1 China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018-2023)
8.2.2 China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2024-2034)
8.2.3 China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type (2018-2034)
8.3 China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application
8.3.1 China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018-2023)
8.3.2 China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2024-2034)
8.3.3 China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth 2018-2034
9.2 APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type
9.2.1 APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018-2023)
9.2.2 APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2024-2034)
9.2.3 APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type (2018-2034)
9.3 APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application
9.3.1 APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018-2023)
9.3.2 APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2024-2034)
9.3.3 APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application (2018-2034)
9.4 APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Sino Biological, Inc.
10.1.1 Sino Biological, Inc. Company Details
10.1.2 Sino Biological, Inc. Business Overview
10.1.3 Sino Biological, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
10.1.4 Sino Biological, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
10.1.5 Sino Biological, Inc. Recent Development
10.2 Cell Signaling Technology, Inc.
10.2.1 Cell Signaling Technology, Inc. Company Details
10.2.2 Cell Signaling Technology, Inc. Business Overview
10.2.3 Cell Signaling Technology, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
10.2.4 Cell Signaling Technology, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
10.2.5 Cell Signaling Technology, Inc. Recent Development
10.3 Bio-Techne
10.3.1 Bio-Techne Company Details
10.3.2 Bio-Techne Business Overview
10.3.3 Bio-Techne 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
10.3.4 Bio-Techne Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
10.3.5 Bio-Techne Recent Development
10.4 OriGene Technologies, Inc.
10.4.1 OriGene Technologies, Inc. Company Details
10.4.2 OriGene Technologies, Inc. Business Overview
10.4.3 OriGene Technologies, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
10.4.4 OriGene Technologies, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
10.4.5 OriGene Technologies, Inc. Recent Development
10.5 Creative Biolabs
10.5.1 Creative Biolabs Company Details
10.5.2 Creative Biolabs Business Overview
10.5.3 Creative Biolabs 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
10.5.4 Creative Biolabs Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
10.5.5 Creative Biolabs Recent Development
10.6 GeneTex
10.6.1 GeneTex Company Details
10.6.2 GeneTex Business Overview
10.6.3 GeneTex 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
10.6.4 GeneTex Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
10.6.5 GeneTex Recent Development
10.7 Arigo Biolaboratories Corp.
10.7.1 Arigo Biolaboratories Corp. Company Details
10.7.2 Arigo Biolaboratories Corp. Business Overview
10.7.3 Arigo Biolaboratories Corp. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
10.7.4 Arigo Biolaboratories Corp. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
10.7.5 Arigo Biolaboratories Corp. Recent Development
10.8 Abcam
10.8.1 Abcam Company Details
10.8.2 Abcam Business Overview
10.8.3 Abcam 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
10.8.4 Abcam Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
10.8.5 Abcam Recent Development
10.9 RayBiotech, Inc.
10.9.1 RayBiotech, Inc. Company Details
10.9.2 RayBiotech, Inc. Business Overview
10.9.3 RayBiotech, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
10.9.4 RayBiotech, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
10.9.5 RayBiotech, Inc. Recent Development
10.10 Biomatik
10.10.1 Biomatik Company Details
10.10.2 Biomatik Business Overview
10.10.3 Biomatik 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
10.10.4 Biomatik Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
10.10.5 Biomatik Recent Development
10.11 Assay Genie
10.11.1 Assay Genie Company Details
10.11.2 Assay Genie Business Overview
10.11.3 Assay Genie 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
10.11.4 Assay Genie Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
10.11.5 Assay Genie Recent Development
10.12 BioLegend
10.12.1 BioLegend Company Details
10.12.2 BioLegend Business Overview
10.12.3 BioLegend 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction
10.12.4 BioLegend Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
10.12.5 BioLegend Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size United States VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Trends
Table 3. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Drivers
Table 4. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Challenges
Table 5. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Restraints
Table 6. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue by Player, (US$ Million), 2018-2023
Table 12. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue Share by Player, 2018-2023
Table 13. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody as of 2024)
Table 15. Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Headquarters and Area Served
Table 16. Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Product and Application
Table 17. Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody in United States, Ranked by Revenue (2024) & (US$ Million)
Table 20. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2024-2034) & (US$ Million)
Table 39. China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 40. China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2024-2034) & (US$ Million)
Table 41. China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 42. China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2024-2034) & (US$ Million)
Table 43. China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2024-2034) & (US$ Million)
Table 51. Sino Biological, Inc. Company Details
Table 52. Sino Biological, Inc. Business Overview
Table 53. Sino Biological, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
Table 54. Sino Biological, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023) & (US$ Million)
Table 55. Sino Biological, Inc. Recent Development
Table 56. Cell Signaling Technology, Inc. Company Details
Table 57. Cell Signaling Technology, Inc. Business Overview
Table 58. Cell Signaling Technology, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
Table 59. Cell Signaling Technology, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023) & (US$ Million)
Table 60. Cell Signaling Technology, Inc. Recent Development
Table 61. Bio-Techne Company Details
Table 62. Bio-Techne Business Overview
Table 63. Bio-Techne 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
Table 64. Bio-Techne Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023) & (US$ Million)
Table 65. Bio-Techne Recent Development
Table 66. OriGene Technologies, Inc. Company Details
Table 67. OriGene Technologies, Inc. Business Overview
Table 68. OriGene Technologies, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
Table 69. OriGene Technologies, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023) & (US$ Million)
Table 70. OriGene Technologies, Inc. Recent Development
Table 71. Creative Biolabs Company Details
Table 72. Creative Biolabs Business Overview
Table 73. Creative Biolabs 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
Table 74. Creative Biolabs Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023) & (US$ Million)
Table 75. Creative Biolabs Recent Development
Table 76. GeneTex Company Details
Table 77. GeneTex Business Overview
Table 78. GeneTex 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
Table 79. GeneTex Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023) & (US$ Million)
Table 80. GeneTex Recent Development
Table 81. Arigo Biolaboratories Corp. Company Details
Table 82. Arigo Biolaboratories Corp. Business Overview
Table 83. Arigo Biolaboratories Corp. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
Table 84. Arigo Biolaboratories Corp. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023) & (US$ Million)
Table 85. Arigo Biolaboratories Corp. Recent Development
Table 86. Abcam Company Details
Table 87. Abcam Business Overview
Table 88. Abcam 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
Table 89. Abcam Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023) & (US$ Million)
Table 90. Abcam Recent Development
Table 91. RayBiotech, Inc. Company Details
Table 92. RayBiotech, Inc. Business Overview
Table 93. RayBiotech, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
Table 94. RayBiotech, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023) & (US$ Million)
Table 95. RayBiotech, Inc. Recent Development
Table 96. Biomatik Company Details
Table 97. Biomatik Business Overview
Table 98. Biomatik 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
Table 99. Biomatik Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023) & (US$ Million)
Table 100. Biomatik Recent Development
Table 101. Assay Genie Company Details
Table 102. Assay Genie Business Overview
Table 103. Assay Genie 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
Table 104. Assay Genie Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023) & (US$ Million)
Table 105. Assay Genie Recent Development
Table 106. BioLegend Company Details
Table 107. BioLegend Business Overview
Table 108. BioLegend 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product
Table 109. BioLegend Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023) & (US$ Million)
Table 110. BioLegend Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product Picture
Figure 2. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size 2018-2034 (US$ Million)
Figure 4. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size 2018-2034 (US$ Million)
Figure 6. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share in Global 2018-2034
Figure 7. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Report Years Considered
Figure 8. Product Picture of Monoclonal Antibody
Figure 9. Product Picture of Polyclonal Antibody
Figure 10. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type in 2024 & 2034
Figure 11. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018-2034) & (US$ Million)
Figure 12. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type (2018-2034)
Figure 13. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type in 2024 & 2034
Figure 14. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2018-2034) & (US$ Million)
Figure 15. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type (2018-2034)
Figure 16. Product Picture of Flow Cytometry
Figure 17. Product Picture of ELISA
Figure 18. Product Picture of Western Blot
Figure 19. Product Picture of Immunoprecipitation
Figure 20. Product Picture of Immunofluorescence
Figure 21. Product Picture of Other
Figure 22. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application in 2024 & 2034
Figure 23. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018-2034) & (US$ Million)
Figure 24. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application (2018-2034)
Figure 25. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application in 2024 & 2034
Figure 26. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2018-2034) & (US$ Million)
Figure 27. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application (2018-2034)
Figure 28. The Top 5 and 10 Largest Companies of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody in the World: Market Share by 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue in 2024
Figure 29. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 30. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Region (2018-2034)
Figure 31. Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate 2018-2034 (US$ Million)
Figure 32. Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type (2018-2034)
Figure 33. Americas 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application (2018-2034)
Figure 34. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. Canada 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 36. Mexico 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 37. Brazil 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 38. EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate 2018-2034 (US$ Million)
Figure 39. EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type (2018-2034)
Figure 40. EMEA 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application (2018-2034)
Figure 41. Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 42. Middle East 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 43. Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 44. China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate 2018-2034 (US$ Million)
Figure 45. China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type (2018-2034)
Figure 46. China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application (2018-2034)
Figure 47. APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate 2018-2034 (US$ Million)
Figure 48. APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type (2018-2034)
Figure 49. APAC 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application (2018-2034)
Figure 50. Japan 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. South Korea 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. China Taiwan 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 53. Southeast Asia 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 54. India 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 55. Sino Biological, Inc. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
Figure 56. Cell Signaling Technology, Inc. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
Figure 57. Bio-Techne Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
Figure 58. OriGene Technologies, Inc. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
Figure 59. Creative Biolabs Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
Figure 60. GeneTex Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
Figure 61. Arigo Biolaboratories Corp. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
Figure 62. Abcam Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
Figure 63. RayBiotech, Inc. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
Figure 64. Biomatik Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
Figure 65. Assay Genie Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
Figure 66. BioLegend Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed